Evidence map›Paper›PMID 35400761›Full record

ArticlePattern recognition2022

Expecting individuals' body reaction to Covid-19 based on statistical Naïve Bayes technique.

Asmaa H Rabie, Nehal A Mansour, Ahmed I Saleh, Ali E Takieldeen

Abstract read
In one paragraph

Article in Pattern recognition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asmaa H RabieComputers and Control Dept. faculty of engineering Mansoura University, Mansoura, Egypt.
Nehal A MansourNile Higher Institute for Engineering and Technology, Artificial intelligence Lab., Mansoura, Egypt.
Ahmed I SalehComputers and Control Dept. faculty of engineering Mansoura University, Mansoura, Egypt.
Ali E TakieldeenIEEE Senior Member, Faculty of Artificial Intelligence, Delta University For Science and Technology, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covid-19, what a strange, unpredictable mutated virus. It has baffled many scientists, as no firm rule has yet been reached to predict the effect that the virus can inflict on people if they are infected with it. Recently, many researches have been introduced for diagnosing Covid-19; however, none of them pay attention to predict the effect of the virus on the person's body if the infection occurs but before the infection really takes place. Predicting the extent to which people will be affected if they are infected with the virus allows for some drastic precautions to be taken for those who will suffer from serious complications, while allowing some freedom for those who expect not to be affected badly. This paper introduces Covid-19 Prudential Expectation Strategy (CPES) as a new strategy for predicting the behavior of the person's body if he has been infected with Covid-19. The CPES composes of three phases called Outlier Rejection Phase (ORP), Feature Selection Phase (FSP), and Classification Phase (CP). For enhancing the classification accuracy in CP, CPES employs two proposed techniques for outlier rejection in ORP and feature selection in FSP, which are called Hybrid Outlier Rejection (HOR) method and Improved Binary Genetic Algorithm (IBGA) method respectively. In ORP, HOR rejects outliers in the training data using a hybrid method that combines standard division and Binary Gray Wolf Optimization (BGWO) method. On the other hand, in FSP, IBGA as a hybrid method selects the most useful features for the prediction process. IBGA includes Fisher Score (F

Indexed as

Covid-19Naïve BayesPredictionPrudential Expectation

Identifiers

PMID35400761
PMCPMC8983097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.